Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Mobile-health Network Solutions Issues 2024 Year-end Letter to Shareholders

In This Article:

SINGAPORE - January 13, 2025 (NEWMEDIAWIRE) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a global leader in telemedicine and digital health innovation, today announced that the Company's co-CEOs, Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician, and Dr. Rachel Teoh Pui Pui, PBM, Family Physician, issued the following Letter to Shareholders regarding the Company's achievements during 2024 and vision for the future.

Dear Shareholders:

We hope each of you had a wonderful Holiday Season, filled with health and happiness for you and your loved ones.

You probably noticed that 2024 was a year of both highs and lows for our Company. As for the highs, after seven years of working with focused determination, we IPO'd on April 10, 2024. In so doing, we achieved many firsts the first telehealth company from APAC to list on a major US stock exchange on Nasdaq, as well as the first from APAC to cross the market cap of $1 billion; it was the dawn of a new era. We were thankful for the unwavering support of our families, friends, and investors who believed in us, journeyed with us, and made our dreams come true. Above all, we are thankful to our employees: Every one of you counts.

At the same time, we were excited at what the future holds for us the vast capital market, at the very heart of innovation and transformation, giving us the opportunity to work and partner with the very best to fulfill our vision of providing the highest quality, comprehensive, near-instant, 24/7 global healthcare platform, accessible and affordable to all. This is the mission and identity that defines us; we will never take this for granted. We remain grounded and pledge to work tirelessly to achieve this goal.

"To Us, Every Day is Day 1"

But there were also the lows, most notably the low share price. Rest assured that we are equally concerned. We remain staunchly committed to maximizing shareholder value in the long term, and believe that MNDR's real value will eventually show up in the share price. We are heartened by the many friends and investors (many of whom we have met in 2024) who believe in us and who continue to cheer us on as we make the rounds of the many investors' conferences in the US. Each day, we wake up with renewed strength, and we are a step closer to our vision.

There was also our regulatory challenge. As MNDR grows and scales, we expect regulatory challenges and scrutiny to come our way. In every state and country we are or will be in, we will continue to work closely with the local Ministry of Health to minimize, if not avoid, similar occurrences. What happened in August 2024 will not distract MNDR from our founding vision. As we close and learn from this unfortunate chapter, we emerge better prepared to navigate forward, and step closer to realizing our vision.